Originally Posted by: Online Community MemberChris given you are asymptomatic re PC and all your "issues" are actually treatment related are you not concerned L177 may give you more issues than it resolves?
What have you medical team said that makes L177 attractive? TBH it's initial promise does not seem to have delivered IMHO. Or is it's early use (in your case) a potential game changer??
I have seen a study of a few men who underwent lut177 treatment in similar circumstances. One had an excellent result some had moderate success and others a failure. There is no guarantee that it will be offered as detailed below.
Thanks Chris
"I reviewed Christopher in clinic today. His recent PSMA PET scan has identified new left internal iliac lymphadenopathy, as well as retroperitoneal lymph nodes, and a highly suspicious left supraclavicular fossa lymph node. There is too much disease here to consider radiotherapy or SABR. I have said I think now is the time to consider further treatment for his cancer. I know Christopher has been loath to consider treatment thus far because of hormonal side-effects.
Ordinarily, the recommendation in this circumstance would be for indefinite LHRH analogues and the addition of a novel anti-androgen. I think in his case, I would use Abiraterone and low dose Prednisolone. I think this is likely to control his cancer for four to five years. An alternative would be to continue observation if he is loath to consider hormone treatment, but we would have to set a threshold or some idea of when we may consider instituting hormone treatment. I think further observation may come with a modest detriment to overall how long he may live.
The third option would be to consider Lutetium-177. This is unorthodox, but I have had one patient where this has occurred. To even consider this, he would have to have a consultation with Dr xxx down in Windsor, and it may be that his insurer will not fund this, but it is certainly a possibility that can be explored."